טוען...

Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma of the Prostate: Southwest Oncology Group (SWOG) S0032

BACKGROUND: This multicenter cooperative group single arm trial assessed the efficacy of a multiagent taxane-based chemotherapy in combination with hormonal therapy in men with metastatic androgen-dependent prostate cancer. METHODS: Forty-one patients with newly diagnosed metastatic prostate cancer...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Smith, David C., Tangen, Cathy M., Hussain, Maha H.A., Van Veldhuizen, Peter J., Harrer, Grant W., Stuart, Robert K., Mills, Glenn M., Vogelzang, Nicholas J., Thompson, Ian M.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2011
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528346/
https://ncbi.nlm.nih.gov/pubmed/21334731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2010.12.043
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!